The risk or severity of adverse effects can be increased when Ergotamine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Astemizole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin. The risk or severity of adverse effects can be increased when Methazolamide is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Gabexate. The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Pravastatin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with St. John's Wort. The risk or severity of adverse effects can be increased when Lapatinib is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Glipizide. The serum concentration of Atorvastatin can be increased when it is combined with Ixazomib. The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Cerivastatin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Perindopril. The serum concentration of Atorvastatin can be increased when it is combined with Aprotinin. The risk or severity of adverse effects can be increased when Pergolide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Glyburide is combined with Atorvastatin. The serum concentration of Tolvaptan can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ambroxol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Phenelzine is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Insulin Pork. The risk or severity of adverse effects can be increased when Dalfopristin is combined with Atorvastatin. The metabolism of Atorvastatin can be decreased when combined with Crisaborole. The serum concentration of Atorvastatin can be increased when it is combined with Darunavir. The risk or severity of adverse effects can be increased when Acetazolamide is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Primidone. Bezafibrate may increase the myopathic rhabdomyolysis activities of Atorvastatin. Raltegravir may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Roxithromycin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ritonavir. The serum concentration of Atorvastatin can be decreased when it is combined with Enzalutamide. The risk or severity of adverse effects can be increased when Luliconazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Trandolapril. The serum concentration of Aliskiren can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sildenafil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Aldesleukin is combined with Atorvastatin. The serum concentration of Mevastatin can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Haloperidol is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Faldaprevir. The serum concentration of Rifaximin can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Perhexiline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Antipyrine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fenofibrate is combined with Atorvastatin. Atorvastatin may increase the anticoagulant activities of Ethyl biscoumacetate. Azithromycin may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Oxymetholone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Cimetidine. The serum concentration of Dabigatran etexilate can be decreased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Zafirlukast is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with 3,4-Dichloroisocoumarin. The risk or severity of adverse effects can be increased when Temsirolimus is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Isradipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Bortezomib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Cyclosporine. The risk or severity of adverse effects can be increased when Bifonazole is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Bosentan. The metabolism of Atorvastatin can be increased when combined with Carbamazepine. The metabolism of Atorvastatin can be increased when combined with Rifapentine. The serum concentration of Atorvastatin can be decreased when it is combined with Magnesium oxide. The risk or severity of adverse effects can be increased when Olaparib is combined with Atorvastatin. The serum concentration of Lanthanum carbonate can be decreased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ezetimibe is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Desipramine is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Acetohexamide. The risk or severity of adverse effects can be increased when Fentanyl is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ranolazine. The risk or severity of adverse effects can be increased when Pazopanib is combined with Atorvastatin. Gemfibrozil may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Omeprazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Imatinib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lomustine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Efonidipine is combined with Atorvastatin. The serum concentration of Silodosin can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Simvastatin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Phosphoramidon. The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Atorvastatin. Atorvastatin may increase the anticoagulant activities of Phenindione. The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Atorvastatin. The serum concentration of Amodiaquine can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Sodium bicarbonate. The serum concentration of Atorvastatin can be increased when it is combined with Bivalirudin. The serum concentration of Atorvastatin can be increased when it is combined with Delanzomib. The serum concentration of Atorvastatin can be decreased when it is combined with Tocilizumab. The risk or severity of adverse effects can be increased when Venlafaxine is combined with Atorvastatin. The metabolism of Atorvastatin can be decreased when combined with Pioglitazone. The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Remikiren. The risk or severity of adverse effects can be increased when Quinidine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Cyproterone acetate. The risk or severity of adverse effects can be increased when Sirolimus is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Asunaprevir. The risk or severity of adverse effects can be increased when Lidocaine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lansoprazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Fosamprenavir. The serum concentration of Atorvastatin can be increased when it is combined with Daclatasvir. The serum concentration of Atorvastatin can be increased when it is combined with Letaxaban. The serum concentration of Atorvastatin can be increased when it is combined with Omapatrilat. The risk or severity of adverse effects can be increased when Caspofungin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Prenylamine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Oxybutynin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Pilocarpine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Levofloxacin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Felodipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Dasabuvir. The risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Flunarizine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nicergoline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Rabeprazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Terconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Irinotecan is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Teniposide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Clofazimine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Abafungin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Rutin is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Tolazamide. The metabolism of Atorvastatin can be increased when combined with Phenobarbital. The risk or severity of adverse effects can be increased when Raloxifene is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Teriflunomide. The serum concentration of Atorvastatin can be increased when it is combined with Fosinopril. The risk or severity of adverse effects can be increased when Metyrapone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Manidipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Deferasirox. The risk or severity of adverse effects can be increased when Ravuconazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline. The risk or severity of adverse effects can be increased when Paramethasone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Abiraterone. The risk or severity of adverse effects can be increased when Fosaprepitant is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lovastatin is combined with Atorvastatin.